Melinda S Yates Selected Research

Melinda S Yates Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 08/2008
14	Endometrial Neoplasms (Endometrial Cancer) 12/2023 - 08/2013
7	Obesity 12/2023 - 10/2009
5	Body Weight (Weight, Body) 01/2017 - 02/2006
4	Carcinogenesis 06/2009 - 02/2006
4	Inflammation (Inflammations) 06/2009 - 02/2006
3	Microsatellite Instability 12/2023 - 08/2017
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 08/2013
3	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 09/2009
2	Endometrial Hyperplasia 11/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 04/2014
1	Adenocarcinoma 12/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Ovarian Epithelial Carcinoma 02/2021
1	Hyperplasia 01/2021
1	Endometrioid Carcinoma 04/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Hyperinsulinism (Hyperinsulinemia) 07/2013
1	Insulin Resistance 07/2013
1	Hyperoxia 11/2009
1	Acute Lung Injury 11/2009
1	Lung Injury 11/2009
1	Critical Illness (Critically Ill) 11/2009
1	Emphysema 01/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2009
1	Chronic Bronchitis 01/2009
1	Pulmonary Hypertension 01/2009
1	Leukemia 08/2008

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 02/2021 - 08/2013
6	Estrogens (Estrogen)FDA Link 01/2021 - 07/2013
6	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 07/2013
5	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 11/2009 - 02/2006
5	TriterpenesIBA 11/2009 - 02/2006
3	Everolimus FDA Link 11/2021 - 03/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 04/2018 - 08/2008
3	Insulin (Novolin)FDA Link 01/2018 - 07/2013
3	imidazoleIBA 11/2009 - 02/2006
3	bardoxoloneIBA 11/2009 - 01/2009
3	EnzymesIBA 11/2009 - 01/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2017
2	Progestins (Progestagens)IBA 11/2020 - 08/2013
2	Letrozole (Femara)FDA LinkGeneric 01/2020 - 03/2015
2	AflatoxinsIBA 08/2008 - 02/2006
1	ParaffinIBA 02/2024
1	Formaldehyde (Formol)FDA Link 02/2024
1	pembrolizumabIBA 12/2023
1	PolymersIBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2021
1	SurvivinIBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2021
1	Retinal DehydrogenaseIBA 01/2021
1	DNA Polymerase IIIBA 11/2020
1	Estrogen ReceptorsIBA 11/2020
1	Progesterone FDA LinkGeneric 11/2020
1	HydrolasesIBA 01/2020
1	UbiquitinIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Protein AggregatesIBA 01/2020
1	pevonedistatIBA 01/2020
1	ProteomeIBA 01/2020
1	Granzymes (Granzyme)IBA 08/2017
1	Phosphotransferases (Kinase)IBA 03/2015
1	BiguanidesIBA 12/2013
1	Oral ContraceptivesIBA 08/2013
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 08/2013
1	DEPOIBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 11/2009
1	Oxygen (Dioxygen)IBA 11/2009
1	AntioxidantsIBA 11/2009
1	LipidsIBA 10/2009
1	NF-E2-Related Factor 2IBA 06/2009
1	SmokeIBA 01/2009
1	TBE 31IBA 08/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008
1	RNA (Ribonucleic Acid)IBA 01/2007
1	Oleanolic AcidIBA 02/2006
1	DNA AdductsIBA 02/2006

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2013
3	Hysterectomy 11/2021 - 07/2020
3	Salpingo-oophorectomy 07/2020 - 03/2011
3	Chemoprevention 09/2009 - 08/2008
2	Immunotherapy 02/2021 - 08/2017
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
1	Intrauterine Devices (Intrauterine Device) 01/2021
1	Salpingectomy 05/2015
1	Oral Administration 11/2009
1	Aftercare (After-Treatment) 01/2009